Medicis Pharmaceutical Corp. (MRX) Misses Q3 EPS by 5c; Guides Q4 EPS Below Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Medicis Pharmaceutical Corp. (NASDAQ: MRX) | Delayed: 70.20 +1.82 (2.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $68.38 | 52 Week High | $44.00 | |||
| Open | $69.60 | 52 Week Low | $30.30 | |||
| Day High | $70.55 | P/E | 101.74 | |||
| Day Low | $67.28 | EPS | $0.69 | |||
| Volume | 721,299 | |||||
